Abstract:Background: With increased longevity in the global aging population, joint health remains critical as the quality of life is increasingly associated with human mobility. Coupled with the growing focus on an active lifestyle, intervention procedures performed on the knee have been gaining popularity, particularly the Anterior Cruciate Ligament (ACL) reconstruction. Such surgical intervention often involves the use of tendon autografts, with semitendinosus and gracilis tendons being popular choices. Nevertheless, less than optimal healing of the tendon graft within the surgically created bone tunnel remains a fundamental problem in this procedure. The proposed solution involves the application of a novel silk fibroin (SF) based sheath, embedded with nanoparticles of low crystallinity hydroxyapatite (nHA), to complement the use of tendon autografts and promote enthesis formation. This SF-nHA sheath configuration is tested against SF sheaths with incorporation of bone morphogenetic protein 2 (BMP-2) only (SF-BMP2), a blend of BMP-2 and nHA (SF-BMP2-nHA) and pure silk sheaths (pure SF) to evaluate their potential in osteointegration of tendon grafts. The optimal sheath type was subsequently put through an in depth assessment for biocompatibility and also in vivo study in a small and large animal model for up to 9 months to evaluate the efficacy of the sheath in promoting osteointegration of tendon grafts. Materials and methods: Knitted SF scaffolds (240 fibroins, L30 Ø5 mm) were first fabricated from raw Bombyx mori silk (Chul Thai Silk Co. Ltd) and subsequently degummed. The nHA precipitates were synthesized by a co-participation method of aqueous (NH4)2HPO4 with aqueous Ca(NO3)2. Hydrothermal treatment of the precipitates' aqueous solution was carried out at 140 C under a pressure 0.3 MPa for 2 h in an autoclave to form the nanograde rod HA crystals. SF sponges, made from a blend of aqueous SF solution (2% w/v) and synthesized nHA (12.9 mg/ ml), were incorporated to the knitted structures via a lyophilization process in a customized mould. This SF-nHA group was compared with pure SF, SF-BMP2 (19.3 mg/ml BMP-2) and SF-BMP2-nHA (19.3 mg/ml BMP-2 and 12.9 mg/ml nHA) via static culture of 10 10 mm specimens with seeded porcine bone marrow derived MSCs (P2, 0.5 10/scaffold) over 28 days. Ex vivo static culture of the four groups of SF sheaths with tendon autografts (porcine Flexor Digitorum Profundus sections, L10 Ø5 mm) and porcine bone marrow derived MSCs (P2, 2 10/scaffold) was then conducted over 28 days. In these assessments, the cellular viability, proliferation, gene expression, collagen deposition levels, scanning electron microscopy (SEM) and histological analyses were performed (n 1⁄4 3). Consequently, the most efficacious group for osteointegration of tendon grafts was selected for the in depth biocompatibility assessments and in vivo tests. The complete optimized sheath was then tested through a series of biocompatibility assessment for cytotoxicity, sensitization, intracutaneous reactivity, acute systemic and 14 days sub-chronic repeated dose toxicity, genotoxicity (Ames test, chromosome aberration assay, mouse lymphoma assay) and 12-weeks implantation in rabbit femur. A preclinical trial was conducted in the porcine ACL reconstruction model using tendon autograft harvested from the flexor digitorium profundus and SF-based sheath sutured onto both ends of the graft. Graft integration in the presence of SF-based sheaths within the bone tunnels and tendon integrity within the intra-articular space were assessed via imaging (CT and MRI), histomorphometrical and histopathological methods at 1, 3, 6 and 9 months time points. All animal experiments were approved by the respective institutional IACUC. Results: The SF sheaths were observed to be porous with interconnected pores. nHA and BMP-2 were observed to be securely incorporated in the lyophilized SF sponges. BMP-2 bioactivity was ascertained after the fabrication process and was shown to be eluting with an initial burst release, followed by a lowered sustained release. MSCs were observed to be viable and proliferative in all four groups of the in vitro study. Increased proliferations were observed in SF-nHA, SF-BMP2 and SF-BMP2-nHA at the early phase (days 1-7) with an accelerated differentiation phase beginning from day 14. Consequently, there was an upregulation of osteogenic related genes (Collagen I (Coll I), Collagen III (Coll III), osteonectin (ON) and osteopontin (OPN)), leading to a significantly increased deposition of collagen by day 21. However, it was further noted that between SF-nHA, SF-BMP2, and SF-BMP2nHA, the presence BMP-2 did not improve upon a persistent (beyond 21 days) upregulation of osteogenic genes and increase in collagen production. When cultured with excised tendon sections, it was observed that cells from within the tendon tend not to participate in interfacial tissue regeneration, while seeded MSCs were viable and produced ECM for bridging the tendon-scaffold interface after 2 weeks in SF-nHA, SF-BMP2, and SF-BMP2-nHA as observed via SEM and H&E staining images. SF sheaths with nHA stimulated osteogenesis from seeded MSCs as observed by the presence of calcium deposits in SFnHA and SF-BMP2-nHA via alizarin red staining. Ossification was thus observed with the presence of nHA, with or without the presence of BMP-2. Consequently, the SF-nHA sheath configuration was selected for further biocompatibility assessment and in vivo testing. The SF-nHA sheath was found to induce discrete intracytoplasmic granules with no cell lysis or reduction in cell growth in the tested mouse connective tissue cell line (NCTC clone 929), indicating non-cytotoxicity. Sensitization tests indicated limited erythema and oedema at challenged skin site over the 48 hours. There were also no significant biological reactivity findings compared to the respective negative control groups in the acute systemic and sub-chronic repeated dose toxicity assessments. Genotoxicity (Ames test) showed that the sheath was non mutagenic in the tested bacterial strains of Salmonella typhimurium and Escherichia coli, while in vitro chromosome aberration test indicated that the sheath did not induce structural chromosome aberration in the cultured mammalian somatic cells. Histopathological assessments of the extracted femurs of the 12 weeks implantation study indicated absence of inflammatory cells with presence of neovascularization and bone ingrowth. At 1 month post ACL reconstruction using the SF-based sheath with tendon autografts in the preclinical porcine model, the reconstructed ACL became taut, when initially the tendon graft was implanted slack. This indicated that there was simultaneous growth and graft remodeling during this period. Regenerated epiligament was also formed, which provided vascularization to the graft. It should be noted that the cartilage of the ACL reconstructed knee remained pristine and clear of cartilage erosion, which was indicative of accelerated and enhanced joint stability soon after the ACL reconstruction. The enhancement in osteointegration of tendon autograft was evident as multiple small foci of mineralization were identified within the femoral and tibial ends of the graft from as early as one month post ACL reconstruction. By 3 months, bone tissue infiltration into the interfacial space was evident from the increase in bone mineralization and vascularized neotissue formation, indicating improved graft to bone integration comparing to control (tendon autograft ACL reconstruction without SF-based sheath). Discussion: Prompt osteointegration of the tendon graft within the bone tunnel post ACL reconstruction was difficult with conventional therapies due to the lack of biochemical precursors. These precursors are provided by the SF-based sheath, which also includes a temporary scaffolding material that helps to provide a snug fit to the bone interface. It will prevent micromotion resulting in early inflammatory reactions, which can lead to the onset of fibrosis. The sheath will also serve a delivery platform for cellular and bioactive components. Progenitor cells, either seeded or attracted from the host into the porous sheath, will reconstitute the native cellular environment of the enthesis by differentiating into chondrocytes and osteoblasts. They will not only deposit the necessary ECM but also cytokines that elicit regenerative responses at the integration site. The delivery of osteogenic factors via the SF-based sheath will accelerate tissue restoration by triggering a migration of host reparative cells. These bioactive agents will also induce cellular differentiation required for the formation of fibrocartilage and bony tissue at the anchorage site. Results from the in vitro study indicated that although BMP-2 led to earlier upregulation of osteogenic genes, the expression of Coll I and ON were not significantly higher in SF-BMP2nHA by day 28 when compared with SFnHA. In terms of protein production, collagen synthesis between SF-nHA and SF-BMP2-nHA were not significant throughout the study, indicating that even though SF-BMP2-nHA might have stimulated the targeted genotypic behavior, the phenotypic outcome was not significantly improved. This was further substantiated when the silk sheaths were cultured with excised porcine tendons, whereby mineralized ECM could be found after 4 weeks of culture in SF-nHA and SF-BMP2-nHA. Balancing clinical needs and our in vitro and ex vivo findings, the SF-nHA sheath was selected for further development. It was found that nHA stimulated tissue infiltration of host bone tissue, resulting in bone tunnel narrowing with new mineralized tissues observed in both the small and large animal models. Consequently, there was enhanced graft-to-host integration progressively over the 9 months implantation period, which potentially resulted in overall mechanical properties closer to that of the native bone-ACL-bon

Augmentation of Tendon Graft Anterior Cruciate Ligament Reconstruction Outcome Using a Silk Based Osteoconductive Sheath

Integration of mesenchymal stem cell sheet and bFGF-loaded fibrin gel in knitted PLGA scaffolds favorable for tendon repair

Anterior Cruciate Ligament Reconstruction in a Rabbit Model Using Silk-Collagen Scaffold and Comparison with Autograft.

Ligament-to-bone Interface Tissue Regeneration Using a Functionalized Biphasic Silk Fibroin Scaffold

Assessment of the advantages and limitations of an innovative silk fibroin scaffold for the reconstruction of the anterior cruciate ligament with preclinical in vitro and in vivo evaluations

ACL reconstruction using a novel hybrid scaffold composed of polyarylate fibers and collagen fibers

Biomechanically, structurally and functionally meticulously tailored polycaprolactone/silk fibroin scaffold for meniscus regeneration

Exogenous stromal derived factor-1 releasing silk scaffold combined with intra-articular injection of progenitor cells promotes bone-ligament-bone regeneration

Bioinspired Silk Fibroin-Based Composite Grafts as Bone Tunnel Fillers for Anterior Cruciate Ligament Reconstruction

Enhancing Tendon-Bone Integration and Healing with Advanced Multi-Layer Nanofiber-Reinforced 3D Scaffolds for Acellular Tendon Complexes

Engineering a functional ACL reconstruction graft containing a triphasic enthesis-like structure in bone tunnel for the enhancement of graft-to-bone integration

Multiphasic bone-ligament-bone integrated scaffold enhances ligamentization and graft-bone integration after anterior cruciate ligament reconstruction

Mesenchymal stromal cells and platelet-rich plasma promote tendon allograft healing in ovine anterior cruciate ligament reconstruction

In Vivo Study of Ligament-Bone Healing after Anterior Cruciate Ligament Reconstruction Using Autologous Tendons with Mesenchymal Stem Cells Affinity Peptide Conjugated Electrospun Nanofibrous Scaffold

Enhancement of osseointegration of polyethylene terephthalate artificial ligament by coating of silk fibroin and depositing of hydroxyapatite.

Dual-layer Aligned-Random Nanofibrous Scaffolds for Improving Gradient Microstructure of Tendon-to-bone Healing in a Rabbit Extra-Articular Model

Canine ACL reconstruction with an injectable hydroxyapatite/collagen paste for accelerated healing of tendon-bone interface

Paper 125: Use of Ad-Osf2 Modified Adipose-derived Stem Cells to Enhance Tendon-Bone Integration in the Reconstruction of ACL

Sequential Intervention of Anti-Inflammatory and Osteogenesis with Silk Fibroin Coated Polyethylene Terephthalate Artificial Ligaments for Anterior Cruciate Ligament Reconstruction.

Ectopic Tissue Engineered Ligament with Silk Collagen Scaffold for Acl Regeneration: A Preliminary Study

Silk Fibroin and Hydroxyapatite Segmented Coating Enhances Graft Ligamentization and Osseointegration Processes of the Polyethylene Terephthalate Artificial Ligament in Vitro and in Vivo.